Harnessing induced pluripotent stem cells and organoids for disease modeling and precision medicine.

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Stem cell research & therapeutics

• Publication date

  2026-02-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/s13287-026-04906-9PMID 41656303PMCID PMC12983725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The future of tumor organoids in precision therapy.

  2025cited by this paper
• Combination of tumor organoids with advanced technologies: A powerful platform for tumor evolution and treatment response (Review)

  2025cited by this paper
• Genotype-phenotype characterization and functional reconstitution of pathogenic β-catenin variants from CTNNB1 syndrome patients

  2025cited by this paper
• Integration of Organoids With CRISPR Screens: A Narrative Review

  2025cited by this paper
• A single-cell multimodal view on gene regulatory network inference from transcriptomics and chromatin accessibility data

  2024cited by this paper
• Establishment of patient-derived organoids and a characterization based drug discovery platform for treatment of gastric cancer

  2024cited by this paper
• Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models

  2024cited by this paper
• A PNPLA3-Deficient iPSC-Derived Hepatocyte Screen Identifies Pathways to Potentially Reduce Steatosis in Metabolic Dysfunction-Associated Fatty Liver Disease

  2024cited by this paper
• Gliovascular transcriptional perturbations in Alzheimer’s disease reveal molecular mechanisms of blood brain barrier dysfunction

  2024cited by this paper
• Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2L914F mutation in endothelial cells

  2024cited by this paper
• Rigor and reproducibility in human brain organoid research: Where we are and where we need to go

  2024cited by this paper
• Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction

  2024cited by this paper
• Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations

  2024cited by this paper
• APOE3ch alleviates Aβ and tau pathology and neurodegeneration in the human APPNL-G-F cerebral organoid model of Alzheimer’s disease

  2024cited by this paper
• Construction of tumor organoids and their application to cancer research and therapy

  2024cited by this paper
• An Organ‐on‐Chip Platform for Simulating Drug Metabolism Along the Gut–Liver Axis

  2024cited by this paper
• Single-Cell Transcriptomic Dataset of RPGR-associated Retinitis Pigmentosa Patient-Derived Retinal Organoids

  2024cited by this paper
• Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy

  2024cited by this paper
• Pancreatic cancer tumor organoids exhibit subtype-specific differences in metabolic profiles

  2024cited by this paper
• Single-cell transcriptomics identifies perturbed molecular pathways in midbrain organoids using α-Synuclein triplication Parkinson's Disease patient-derived iPSCs.

  2023cited by this paper
• ABCA7 deficiency causes neuronal dysregulation by altering mitochondrial lipid metabolism

  2023cited by this paper
• Organoid co‐culture models of the tumor microenvironment promote precision medicine

  2023cited by this paper
• Vascular organs-on-chip made with patient-derived endothelial cells: technologies to transform drug discovery and disease modeling

  2023cited by this paper
• Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges

  2023cited by this paper
• Novel molecular classification and prognosis of papillary renal cell carcinoma based on a large-scale CRISPR-Cas9 screening and machine learning

  2023cited by this paper
• Advances towards the use of gastrointestinal tumor patient-derived organoids as a therapeutic decision-making tool

  2023cited by this paper
• Recent Research Trends in Stem Cells Using CRISPR/Cas-Based Genome Editing Methods

  2023cited by this paper
• In-organoid single-cell CRISPR screening reveals determinants of hepatocyte differentiation and maturation

  2023cited by this paper
• Cerebral organoids derived from patients with Alzheimer's disease with PSEN1/2 mutations have defective tissue patterning and altered development.

  2023cited by this paper
• Mavacamten, a precision medicine for hypertrophic cardiomyopathy: From a motor protein to patients

  2023cited by this paper
• Elucidating the Proximal Tubule HNF4A Gene Regulatory Network in Human Kidney Organoids

  2023cited by this paper
• Predicting cell morphological responses to perturbations using generative modeling

  2023cited by this paper
• Prime editing: advances and therapeutic applications.

  2023cited by this paper
• Functional precision oncology using patient-derived assays: bridging genotype and phenotype

  2023cited by this paper
• Generation and characterization of NGLY1 patient-derived midbrain organoids

  2023cited by this paper
• A Three-Dimensional Engineered Cardiac In Vitro Model: Controlled Alignment of Cardiomyocytes in 3D Microphysiological Systems

  2023cited by this paper
• The Efficacy of Using Patient-Derived Organoids to Predict Treatment Response in Colorectal Cancer

  2023cited by this paper
• Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma

  2022cited by this paper
• Clinical translation of patient-derived tumour organoids- bottlenecks and strategies

  2022cited by this paper
• CRISPRi screens in human iPSC-derived astrocytes elucidate regulators of distinct inflammatory reactive states

  2022cited by this paper
• Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers

  2022cited by this paper
• A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states

  2022cited by this paper
• Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients

  2022cited by this paper
• SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis

  2021cited by this paper
• Genome-wide CRISPR/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages

  2021cited by this paper
• Patient-derived organoids as a predictive biomarker for treatment response in cancer patients

  2021cited by this paper
• Technological readiness and implementation of genomic‐driven precision medicine for complex diseases

  2021cited by this paper
• Genome-wide CRISPR/Cas9 screening in human iPS derived cardiomyocytes uncovers novel mediators of doxorubicin cardiotoxicity

  2021cited by this paper
• The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update

  2021cited by this paper
• Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma

  2021cited by this paper
• The role of patient-derived ovarian cancer organoids in the study of PARP inhibitors sensitivity and resistance: from genomic analysis to functional testing

  2021cited by this paper
• Single-cell normalization and association testing unifying CRISPR screen and gene co-expression analyses with Normalisr

  2021cited by this paper
• Microfluidic-Chip-Integrated Biosensors for Lung Disease Models

  2021cited by this paper
• Gene Editing in Pluripotent Stem Cells and Their Derived Organoids

  2021cited by this paper
• Viscoelasticity Acts as a Marker for Tumor Extracellular Matrix Characteristics

  2021cited by this paper
• Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq

  2021cited by this paper
• Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank

  2021cited by this paper
• Lupus Heart Disease Modeling with Combination of Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Lupus Patient Serum

  2021cited by this paper
• TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models

  2021cited by this paper
• Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients

  2020cited by this paper
• Genome-Scale CRISPR Screening in Human Intestinal Organoids Identifies Drivers of TGF-β Resistance.

  2020cited by this paper
• Patient-Specific Retinal Organoids Recapitulate Disease Features of Late-Onset Retinitis Pigmentosa

  2020cited by this paper
• Standardized GMP-compliant scalable production of human pancreas organoids

  2020cited by this paper
• Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems

  2020cited by this paper
• Organoid and pluripotent stem cells in Parkinson’s disease modeling: an expert view on their value to drug discovery

  2020cited by this paper
• CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma

  2020cited by this paper
• Controlling and enhancing CRISPR systems

  2020cited by this paper
• CRISPRidentify: identification of CRISPR arrays using machine learning approach

  2020cited by this paper
• An efficient KRAB domain for CRISPRi applications in human cells

  2020cited by this paper
• Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment

  2020cited by this paper
• Human organoids: model systems for human biology and medicine

  2020cited by this paper
• O‐glycan initiation directs distinct biological pathways and controls epithelial differentiation

  2020cited by this paper
• Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids.

  2019cited by this paper
• Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In Vivo and In Vitro

  2019cited by this paper
• Pancreatic cancer organoids recapitulate disease and allow personalized drug screening

  2019cited by this paper
• Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids.

  2019cited by this paper
• Advances in Hydrogels in Organoids and Organs‐on‐a‐Chip

  2019cited by this paper
• Patient-derived pancreas-on-a-chip to model cystic fibrosis-related disorders

  2019cited by this paper
• Single-cell analysis of a mutant library generated using CRISPR-guided deaminase in human melanoma cells

  2019cited by this paper
• Cancer modeling meets human organoid technology

  2019cited by this paper
• Patient-derived tumor organoids for prediction of cancer treatment response.

  2018cited by this paper
• The Physical and Biochemical Properties of the Extracellular Matrix Regulate Cell Fate.

  2018cited by this paper
• Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression.

  2018cited by this paper
• Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells

  2018cited by this paper
• Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids.

  2018cited by this paper
• Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes.

  2018cited by this paper
• CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells

  2017cited by this paper
• Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.

  2017cited by this paper
• Using brain organoids to understand Zika virus-induced microcephaly

  2017cited by this paper
• Self-Organized Cerebral Organoids with Human-Specific Features Predict Effective Drugs to Combat Zika Virus Infection.

  2017cited by this paper
• Repurposing CRISPR System for Transcriptional Activation.

  2017cited by this paper
• Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders

  2016cited by this paper
• Designer matrices for intestinal stem cell and organoid culture

  2016cited by this paper
• The FAIR Guiding Principles for scientific data management and stewardship

  2016cited by this paper
• Translation of Genotype to Phenotype by a Hierarchy of Cell Subsystems

  2016cited by this paper
• A microfluidic optical platform for real-time monitoring of pH and oxygen in microfluidic bioreactors and organ-on-chip devices.

  2016cited by this paper
• Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids

  2015cited by this paper
• Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids

  2015cited by this paper
• Disease-in-a-dish: the contribution of patient-specific induced pluripotent stem cell technology to regenerative rehabilitation.

  2014cited by this paper
• Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons.

  2014cited by this paper

• No citing papers are available for this paper.